IDIOPATHIC PULMONARY FIBROSIS, ACUTE FATAL FORM

Clinical trials for IDIOPATHIC PULMONARY FIBROSIS, ACUTE FATAL FORM explained in plain language.

Never miss a new study

Get alerted when new IDIOPATHIC PULMONARY FIBROSIS, ACUTE FATAL FORM trials appear

Sign up with your email to follow new studies for IDIOPATHIC PULMONARY FIBROSIS, ACUTE FATAL FORM, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Completed 1

New hope for deadly lung crisis: experimental combo therapy tested

Disease control Completed

This study tested a new combination treatment for patients experiencing a sudden, life-threatening worsening of their lung scarring disease (idiopathic pulmonary fibrosis). Researchers compared an intensive regimen of plasma exchange, the drug rituximab, and immunoglobulin infusi…

Matched conditions: IDIOPATHIC PULMONARY FIBROSIS, ACUTE FATAL FORM

Phase: PHASE2 • Sponsor: University of Alabama at Birmingham • Aim: Disease control

Last updated Apr 03, 2026 14:42 UTC

IDIOPATHIC PULMONARY FIBROSIS, ACUTE FATAL FORM

Get alerted when new IDIOPATHIC PULMONARY FIBROSIS, ACUTE FATAL FORM trials appear

New hope for deadly lung crisis: experimental combo therapy tested